DIFFUSION PHARMACEUTICALS IN (DFFN) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:DFFN • US2537484048

4.4 USD
+0.46 (+11.68%)
At close: Aug 16, 2023
4.46 USD
+0.06 (+1.36%)
After Hours: 8/16/2023, 8:00:02 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to DFFN. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 40.8. This target is 827.27% above the current price.
  • DFFN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DFFN.
  • In the previous month the buy percentage consensus was at a similar level.
  • DFFN was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

DFFN Historical Analyst RatingsDFFN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -61 -55 -49 -43 -37 -31 -25 -19 -13 -7 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 4.4040.4040.8040.8042.00 - 818.18% 827.27% 827.27% 854.55%

Related screens

DFFN Current Analyst RatingDFFN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2022-08-16 HC Wainwright & Co. Upgrade Neutral -> Buy

DIFFUSION PHARMACEUTICALS IN / DFFN FAQ

What do analysts expect the price target to be for DIFFUSION PHARMACEUTICALS IN (DFFN)?

7 analysts have analysed DFFN and the average price target is 40.8 USD. This implies a price increase of 827.27% is expected in the next year compared to the current price of 4.4.


What is the consensus rating for DIFFUSION PHARMACEUTICALS IN (DFFN) stock?

The consensus rating for DIFFUSION PHARMACEUTICALS IN (DFFN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.